{"id":"W2330470789","doi":"10.1111/apt.13594","title":"Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Faecal calprotectin; Calprotectin; Gastroenterology; Cohort; Crohn's disease; Clinical endpoint; Infliximab; Disease; Clinical trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006039224,0.000328845,0.0005049172,0.0006075783,0.00045662,0.0006642517,0.0003354429,0.0005383857,0.002121257],"category_scores_gemma":[0.001245074,0.0003797573,0.0004073327,0.001136484,0.0003392701,0.0003917227,0.0004693996,0.0003734498,0.0004547891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005532068,"about_ca_system_score_gemma":0.0005911604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005852601,"about_ca_topic_score_gemma":0.007306305,"domain_scores_codex":[0.9992482,0.000184064,0.0000767358,0.0002447052,0.0001007544,0.0001455329],"domain_scores_gemma":[0.9990788,0.000114156,0.0004168715,0.00009378584,0.0001016555,0.0001946784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002890469,0.0001087878,0.9972672,0.00003364103,0.00007054862,0.0002449444,0.0001553296,0.00002154437,0.0002170362,0.00002791408,0.0002093459,0.001354567],"study_design_scores_gemma":[0.00006884037,0.0003150327,0.9983467,0.00001261787,0.0000514292,0.0004079429,0.0002164439,0.00008873662,0.00002380639,0.00001413714,0.0004496363,0.000004603535],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989073,0.0003082451,0.00006454962,0.00003242763,0.000004546518,0.00003914172,0.0003254671,0.000001706491,0.0003166894],"genre_scores_gemma":[0.9990156,0.0001668118,0.00007391893,0.00006683695,0.00001044127,0.00003480971,0.0004871906,0.000001668242,0.0001427283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005852601,"threshold_uncertainty_score":0.01163709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02581335356990763,"score_gpt":0.379374458718892,"score_spread":0.3535611051489843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}